Triple-Threat attack on tough colon cancer before surgery
Disease control
Recruiting now
This study is testing if adding two drugs (an immunotherapy called a PD-1 antibody and a drug called bevacizumab) to standard chemotherapy before surgery works better than chemotherapy alone for people with a specific type of locally advanced colon or rectal cancer. The goal is t…
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC